Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|HER2-negative Breast Cancer
Sponsor: Eisai Co., Ltd.